HCA Healthcare, Inc. (NYSE:HCA) will release earnings for its first quarter before the opening bell on Friday, April 24.

Analysts expect the Nashville, Tennessee-based company to report quarterly earnings of $7.15 per share, up from $6.45 per share in the year-ago period. The consensus estimate for HCA Healthcare's quarterly revenue is $19.07 billion (it reported $18.32 billion last year), according to Benzinga Pro.

On Jan. 27, HCA Healthcare released mixed fourth-quarter 2025 financial results.

HCA Healthcare shares gained 0.6% to close at $474.03 on Thursday.

Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.

Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.

  • Mizuho analyst Ann Hynes maintained an Outperform rating and raised the price target from $540 to $585 on Feb. 25, 2026. This analyst has an accuracy rate of 70%.
  • UBS analyst Andrew Mok maintained a Buy rating and raised the price target from $598 to $635 on Feb. 23, 2026. This analyst has an accuracy rate of 59%.
  • JP Morgan analyst Benjamin Rossi maintained a Neutral rating and boosted the price target from $420 to $535 on Feb. 20, 2026. This analyst has an accuracy rate of 51%.
  • Argus Research analyst David Toung maintained a Buy rating and raised the price target from $530 to $560 on Feb. 6, 2026. This analyst has an accuracy rate of 67%.
  • Wells Fargo analyst Stephen Baxter maintained an Equal-Weight rating and boosted the price target from $452 to $481 on Jan. 30, 2026. This analyst has an accuracy rate of 56%.

Considering buying HCA stock? Here’s what analysts think:

Photo via Shutterstock